Biotech company with an oral drug for Hidradenitis Suppurativa
AI-generated insights about InflaRx N.V. from various financial sources
The speaker expresses extreme regret over buying the stock, calling it a 'fucking dog' and using it as an example of a position that should be sold to cut losses.
The speaker is long the stock and bullish on its prospects, mentioning it was one of his 'tons of different positions'.
The speaker holds a losing position, refers to the stock as 'shit' and 'dog poopoo', is down over 20%, and expresses regret over the trade. He is not adding to the position, using it as an example of a loser to let go.
The speaker is long, viewing the stock as "pretty cheap" with a promising drug in a large market, but notes it's a long-term hold that could require sitting on for a year.
The speaker expresses extreme regret over buying the stock, calling it a 'fucking dog' and using it as an example of a position that should be sold to cut losses.
The speaker is long the stock and bullish on its prospects, mentioning it was one of his 'tons of different positions'.
The speaker holds a losing position, refers to the stock as 'shit' and 'dog poopoo', is down over 20%, and expresses regret over the trade. He is not adding to the position, using it as an example of a loser to let go.
The speaker is long, viewing the stock as "pretty cheap" with a promising drug in a large market, but notes it's a long-term hold that could require sitting on for a year.